| Primary |
| Acute Myocardial Infarction |
17.4% |
| Drug Use For Unknown Indication |
16.6% |
| Myocardial Infarction |
14.9% |
| Product Used For Unknown Indication |
12.5% |
| Percutaneous Coronary Intervention |
11.8% |
| Ill-defined Disorder |
4.9% |
| Angioplasty |
2.6% |
| Stent Placement |
2.3% |
| Prophylaxis |
2.3% |
| Anticoagulant Therapy |
2.2% |
| Angina Pectoris |
2.2% |
| Coronary Angioplasty |
2.2% |
| Acute Coronary Syndrome |
1.9% |
| Hypertension |
1.0% |
| Thrombosis |
1.0% |
| Thrombosis Prophylaxis |
0.9% |
| Coronary Artery Disease |
0.9% |
| Catheterisation Cardiac |
0.8% |
| Coronary Arterial Stent Insertion |
0.7% |
| Embolism |
0.7% |
|
| Thrombocytopenia |
14.7% |
| Death |
11.1% |
| Thrombosis In Device |
8.3% |
| Incorrect Route Of Drug Administration |
7.0% |
| Haemorrhage Intracranial |
6.4% |
| Haemorrhage |
4.9% |
| Pulmonary Haemorrhage |
4.7% |
| Retroperitoneal Haemorrhage |
4.5% |
| Gastrointestinal Haemorrhage |
4.3% |
| Myocardial Infarction |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Ventricular Tachycardia |
4.1% |
| Cardiac Tamponade |
3.2% |
| Infarction |
3.0% |
| Pericardial Haemorrhage |
2.8% |
| Platelet Count Decreased |
2.8% |
| Renal Failure Acute |
2.6% |
| Shock Haemorrhagic |
2.6% |
| Cerebral Haemorrhage |
2.3% |
| Pharmaceutical Product Counterfeit |
2.3% |
|
| Secondary |
| Acute Myocardial Infarction |
39.8% |
| Myocardial Infarction |
14.7% |
| Product Used For Unknown Indication |
11.5% |
| Percutaneous Coronary Intervention |
9.9% |
| Drug Use For Unknown Indication |
8.9% |
| Ill-defined Disorder |
1.8% |
| Stent Placement |
1.7% |
| Angioplasty |
1.5% |
| Anticoagulant Therapy |
1.4% |
| Acute Coronary Syndrome |
1.2% |
| Angina Pectoris |
1.1% |
| Catheterisation Cardiac |
1.1% |
| Prophylaxis |
1.0% |
| Kawasaki's Disease |
0.9% |
| Coronary Angioplasty |
0.6% |
| Hypertension |
0.6% |
| Cardiogenic Shock |
0.6% |
| Peripheral Ischaemia |
0.6% |
| Coronary Artery Disease |
0.5% |
| Coronary Artery Thrombosis |
0.5% |
|
| Thrombocytopenia |
13.4% |
| Coronary Artery Stenosis |
10.9% |
| Thrombosis In Device |
10.9% |
| Ventricular Fibrillation |
9.7% |
| Ventricular Tachycardia |
6.7% |
| Coronary Artery Disease |
6.2% |
| Incorrect Route Of Drug Administration |
4.7% |
| Pharmaceutical Product Counterfeit |
3.7% |
| Renal Failure Acute |
3.7% |
| Myocardial Ischaemia |
3.5% |
| Cardiac Tamponade |
3.2% |
| Pneumonia |
3.2% |
| Coronary Artery Thrombosis |
2.7% |
| Haemorrhage |
2.7% |
| Retroperitoneal Haemorrhage |
2.7% |
| Subarachnoid Haemorrhage |
2.7% |
| Gastrointestinal Haemorrhage |
2.5% |
| Pulmonary Oedema |
2.2% |
| Shock Haemorrhagic |
2.2% |
| Death |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.5% |
| Percutaneous Coronary Intervention |
15.1% |
| Drug Use For Unknown Indication |
10.0% |
| Myocardial Infarction |
5.9% |
| Acute Coronary Syndrome |
5.7% |
| Acute Myocardial Infarction |
5.4% |
| Coronary Artery Bypass |
4.6% |
| Pain |
3.8% |
| Catheterisation Cardiac |
3.2% |
| Infarction |
2.4% |
| Dyspepsia |
1.9% |
| Nervousness |
1.9% |
| Stent Placement |
1.9% |
| Angiogram |
1.6% |
| Anticoagulant Therapy |
1.6% |
| Hypertension |
1.1% |
| Postoperative Wound Infection |
1.1% |
| Angioplasty |
0.8% |
| Asthma |
0.8% |
| Chest Pain |
0.8% |
|
| Vomiting |
12.5% |
| Thrombosis In Device |
10.2% |
| Acute Myocardial Infarction |
6.8% |
| Coronary Artery Surgery |
6.8% |
| Thrombocytopenia |
6.8% |
| Cardiac Death |
5.7% |
| Ventricular Fibrillation |
5.7% |
| Coronary Artery Disease |
4.5% |
| Coronary Revascularisation |
4.5% |
| Death |
4.5% |
| Gastrointestinal Haemorrhage |
4.5% |
| Retroperitoneal Haemorrhage |
4.5% |
| Anxiety |
3.4% |
| Cerebral Haemorrhage |
3.4% |
| Coronary Artery Occlusion |
3.4% |
| Haemorrhage Intracranial |
3.4% |
| Cardiac Tamponade |
2.3% |
| Chest Pain |
2.3% |
| Fear |
2.3% |
| Haemorrhagic Stroke |
2.3% |
|
| Interacting |
| Acute Myocardial Infarction |
46.2% |
| Coronary Artery Thrombosis |
23.1% |
| Arrhythmia |
7.7% |
| Coronary Artery Disease |
7.7% |
| Hypotension |
7.7% |
| Sedation |
7.7% |
|
| Shock Haemorrhagic |
50.0% |
| Upper Gastrointestinal Haemorrhage |
50.0% |
|
